The commercial banker operating mostly in Texas posted revenue ... This $7.4 billion settlement pact with OxyContin maker Purdue Pharma is about 25% more ...

OxyContin’s meteoric commercial success was entirely the product of Purdue ... It is tempting to lay the blame for this crisis squarely at the feet of the Sackler family and Purdue Pharma. After all, ...

HB 1004 centers on the prices hospital systems charge patients covered by commercial health insurance, typically provided by their employers. A recurring study updated in December by research ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

As the five-year anniversary of the Archdiocese of New Orleans bankruptcy case approaches, the judge wants to speed up settlement talks and is planning to name a third mediator — Judge Christopher ...

Q: If you had 30 seconds to describe your practice, what would you say? A: I am a partner in AGG’s Litigation & Dispute Resolution practice, ...

PORTLAND, IL, UNITED STATES, February 3, 2025 /EINPresswire / -- According to the recent report released by Allied market Research, the global transdermal drug delivery systems market size is ...

Throughout her career, Ms. Colacot has led quality functions across clinical, research and development, commercial ... Pharma Inc., McNeil Consumer Healthcare, and Laureate Pharma Inc/Purdue ...

3D printing has already reached the commercial stage in pharma, after Aprecia Pharmaceuticals ... and last week formed a partnership with Purdue University to help refine the use of 3D printing ...

Teva is trying to be part of the solution, and not the problem, but suspicions about the pharma industry's role in the abuse epidemic are running high. Purdue markets OxyContin, and is facing ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...